Relationship between multimorbidity, demographic factors and mortality: findings from the UK Biobank cohort - PubMed (original) (raw)
Relationship between multimorbidity, demographic factors and mortality: findings from the UK Biobank cohort
Bhautesh Dinesh Jani et al. BMC Med. 2019.
Abstract
Background: Multimorbidity is associated with higher mortality, but the relationship with cancer and cardiovascular mortality is unclear. The influence of demographics and type of condition on the relationship of multimorbidity with mortality remains unknown. We examine the relationship between multimorbidity (number/type) and cause of mortality and the impact of demographic factors on this relationship.
Methods: Data source: the UK Biobank; 500,769 participants; 37-73 years; 53.7% female. Exposure variables: number and type of long-term conditions (LTCs) (N = 43) at baseline, modelled separately. Cox regression models were used to study the impact of LTCs on all-cause/vascular/cancer mortality during median 7-year follow-up. All-cause mortality regression models were stratified by age/sex/socioeconomic status.
Results: All-cause mortality is 2.9% (14,348 participants). Of all deaths, 8350 (58.2%) were cancer deaths and 2985 (20.8%) vascular deaths. Dose-response relationship is observed between the increasing number of LTCs and all-cause/cancer/vascular mortality. A strong association is observed between cardiometabolic multimorbidity and all three clinical outcomes; non-cardiometabolic multimorbidity (excluding cancer) is associated with all-cause/vascular mortality. All-cause mortality risk for those with ≥ 4 LTCs was nearly 3 times higher than those with no LTCs (HR 2.79, CI 2.61-2.98); for ≥ 4 cardiometabolic conditions, it was > 3 times higher (HR 3.20, CI 2.56-4.00); and for ≥ 4 non-cardiometabolic conditions (excluding cancer), it was 50% more (HR 1.50, CI 1.36-1.67). For those with ≥ 4 LTCs, morbidity combinations that included cardiometabolic conditions, chronic kidney disease, cancer, epilepsy, chronic obstructive pulmonary disease, depression, osteoporosis and connective tissue disorders had the greatest impact on all-cause mortality. In the stratified model by age/sex, absolute all-cause mortality was higher among the 60-73 age group with an increasing number of LTCs; however, the relative effect size of the increasing number of LTCs on higher mortality risk was larger among those 37-49 years, especially men. While socioeconomic status was a significant predictor of all-cause mortality, mortality risk with increasing number of LTCs remained constant across different socioeconomic gradients.
Conclusions: Multimorbidity is associated with higher all-cause/cancer/vascular mortality. Type, as opposed to number, of LTCs may have an important role in understanding the relationship between multimorbidity and mortality. Multimorbidity had a greater relative impact on all-cause mortality in middle-aged as opposed to older populations, particularly males, which deserves exploration.
Keywords: Cancer mortality; Condition clusters; Mortality; Multimorbidity; Vascular mortality.
Conflict of interest statement
Ethics approval and consent to participate
All participants gave informed consent for data provision and linkage. UK Biobank has full ethical approval from the NHS National Research Ethics Service (16/NW/0274).
Consent for publication
The authors confirm that this manuscript does not contain any personal data or images from any individual participants.
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Figures
Fig. 1
Cumulative survival plot showing the probability of all-cause mortality among the UK Biobank participants with different levels of multimorbidity. N = 500,769 UK Biobank participants; LTCs long-term conditions
Fig. 2
Cumulative survival plot showing the probability of cancer and vascular mortality among the UK Biobank participants with different levels of multimorbidity. N = 500,769 UK Biobank participants; LTCs long-term conditions
Fig. 3
The relationship between age, sex and multimorbidity in predicting all-cause mortality. N = 500,769. LTCs long-term conditions. Two asterisks indicate the results adjusted for socioeconomic status (Townsend score), smoking status, alcohol consumption, BMI, and physical activity levels at baseline
Fig. 4
The relationship between socioeconomic status and multimorbidity in predicting all-cause mortality. N = 500,143. LTCs long-term conditions. Socioeconomic status classified based on Townsend score quintiles. Two asterisks indicate the results adjusted for age, sex, smoking status, alcohol consumption, BMI and physical activity levels at baseline
Similar articles
- Patterns of multimorbidity and their effects on adverse outcomes in rheumatoid arthritis: a study of 5658 UK Biobank participants.
McQueenie R, Nicholl BI, Jani BD, Canning J, Macdonald S, McCowan C, Neary J, Browne S, Mair FS, Siebert S. McQueenie R, et al. BMJ Open. 2020 Nov 23;10(11):e038829. doi: 10.1136/bmjopen-2020-038829. BMJ Open. 2020. PMID: 33234629 Free PMC article. - Associations between multimorbidity and adverse health outcomes in UK Biobank and the SAIL Databank: A comparison of longitudinal cohort studies.
Hanlon P, Jani BD, Nicholl B, Lewsey J, McAllister DA, Mair FS. Hanlon P, et al. PLoS Med. 2022 Mar 7;19(3):e1003931. doi: 10.1371/journal.pmed.1003931. eCollection 2022 Mar. PLoS Med. 2022. PMID: 35255092 Free PMC article. - Multimorbidity, polypharmacy, and COVID-19 infection within the UK Biobank cohort.
McQueenie R, Foster HME, Jani BD, Katikireddi SV, Sattar N, Pell JP, Ho FK, Niedzwiedz CL, Hastie CE, Anderson J, Mark PB, Sullivan M, O'Donnell CA, Mair FS, Nicholl BI. McQueenie R, et al. PLoS One. 2020 Aug 20;15(8):e0238091. doi: 10.1371/journal.pone.0238091. eCollection 2020. PLoS One. 2020. PMID: 32817712 Free PMC article. - Adapting the definition of multimorbidity - development of a locality-based consensus for selecting included Long Term Conditions.
Hafezparast N, Turner EB, Dunbar-Rees R, Vodden A, Dodhia H, Reynolds B, Reichwein B, Ashworth M. Hafezparast N, et al. BMC Fam Pract. 2021 Jun 23;22(1):124. doi: 10.1186/s12875-021-01477-x. BMC Fam Pract. 2021. PMID: 34162331 Free PMC article. Review. - CHOICE: Choosing Health Options In Chronic Care Emergencies.
Guthrie E, Afzal C, Blakeley C, Blakemore A, Byford R, Camacho E, Chan T, Chew-Graham C, Davies L, de Lusignan S, Dickens C, Drinkwater J, Dunn G, Hunter C, Joy M, Kapur N, Langer S, Lovell K, Macklin J, Mackway-Jones K, Ntais D, Salmon P, Tomenson B, Watson J. Guthrie E, et al. Southampton (UK): NIHR Journals Library; 2017 Jul. Southampton (UK): NIHR Journals Library; 2017 Jul. PMID: 28767210 Free Books & Documents. Review.
Cited by
- Association of latent class analysis-derived multimorbidity clusters with adverse health outcomes in patients with multiple long-term conditions: comparative results across three UK cohorts.
Krauth SJ, Steell L, Ahmed S, McIntosh E, Dibben GO, Hanlon P, Lewsey J, Nicholl BI, McAllister DA, Smith SM, Evans R, Ahmed Z, Dean S, Greaves C, Barber S, Doherty P, Gardiner N, Ibbotson T, Jolly K, Ormandy P, Simpson SA, Taylor RS, Singh SJ, Mair FS, Jani BD; PERFORM research team. Krauth SJ, et al. EClinicalMedicine. 2024 Jun 28;74:102703. doi: 10.1016/j.eclinm.2024.102703. eCollection 2024 Aug. EClinicalMedicine. 2024. PMID: 39045545 Free PMC article. - Education and income-related inequalities in multimorbidity among older Brazilian adults.
Bof de Andrade F, Thumé E, Facchini LA, Torres JL, Nunes BP. Bof de Andrade F, et al. PLoS One. 2022 Oct 13;17(10):e0275985. doi: 10.1371/journal.pone.0275985. eCollection 2022. PLoS One. 2022. PMID: 36227899 Free PMC article. - Ethnic and socioeconomic differences in SARS-CoV-2 infection: prospective cohort study using UK Biobank.
Niedzwiedz CL, O'Donnell CA, Jani BD, Demou E, Ho FK, Celis-Morales C, Nicholl BI, Mair FS, Welsh P, Sattar N, Pell JP, Katikireddi SV. Niedzwiedz CL, et al. BMC Med. 2020 May 29;18(1):160. doi: 10.1186/s12916-020-01640-8. BMC Med. 2020. PMID: 32466757 Free PMC article. - Prevalence and factors associated with multimorbidity among primary care patients with decreased renal function.
Hirst JA, Ordóñez Mena JM, O'Callaghan CA, Ogburn E, Taylor CJ, Yang Y, Hobbs FDR. Hirst JA, et al. PLoS One. 2021 Jan 15;16(1):e0245131. doi: 10.1371/journal.pone.0245131. eCollection 2021. PLoS One. 2021. PMID: 33449936 Free PMC article. Clinical Trial. - Non-communicable disease, sociodemographic factors, and risk of death from infection: a UK Biobank observational cohort study.
Drozd M, Pujades-Rodriguez M, Lillie PJ, Straw S, Morgan AW, Kearney MT, Witte KK, Cubbon RM. Drozd M, et al. Lancet Infect Dis. 2021 Aug;21(8):1184-1191. doi: 10.1016/S1473-3099(20)30978-6. Epub 2021 Mar 1. Lancet Infect Dis. 2021. PMID: 33662324 Free PMC article.
References
- Academy of Medical Sciences. Multimorbidity: a priority for global health research. 2018. https://acmedsci.ac.uk/file-download/82222577. Accessed 18 Mar 2019.
- Arokiasamy P, Uttamacharya U, Jain K, Biritwum RB, Yawson AE, Wu F, et al. The impact of multimorbidity on adult physical and mental health in low- and middle-income countries: what does the study on global ageing and adult health (SAGE) reveal? BMC Med. 2015;13:178. doi: 10.1186/s12916-015-0402-8. - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources